Nektar Therapeutics
NKTR
NKTR
228 hedge funds and large institutions have $561M invested in Nektar Therapeutics in 2022 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 69 increasing their positions, 73 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
228
Holders Change
+3
Holders Change %
+1.33%
% of All Funds
3.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
69
Reduced
73
Closed
25
Calls
$2M
Puts
$219K
Net Calls
+$1.78M
Net Calls Change
-$1.41M
Top Buyers
| 1 |
1
BlackRock
New York
|
$112M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$74.1M |
| 3 |
3
Northern Trust
Chicago,
Illinois
|
$5.98M |
| 4 |
4
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$3.32M |
| 5 |
5
Federated Hermes
Pittsburgh,
Pennsylvania
|
$2.68M |
